医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Hoya Reports Fourth Quarter and Full-Year Financial Results

2013年05月08日 PM07:55
このエントリーをはてなブックマークに追加


 

TOKYO

HOYA Corporation (TOKYO:7741) today announced financial results for the fourth quarter and full-year ended March 31, 2013. During the quarter, revenues from all operations increased 9.8% to 96,095 million yen compared with the same period last year. Profit before tax increased 69.7% to 29,965 million yen and profit for the term increased 102.5% to 23,239 million yen year on year. This significant increase in profit is due to the recording of 14,275 million yen of insurance income in the form compensation for the fixed assets and for the lost profit suffered from the Thai flooding.

For the fiscal year ended March 31, 2013, revenues from all operations were 372,494 million yen, down 1.2% year on year mainly due to business transfer of Pentax Imaging Systems in October 2011. Profit before tax was up 52.7% to 89,368 million yen, and profit for the term was up 66.9% to 71,242 million yen over the previous fiscal year. The income from Thai flooding insurance for the year amounted 32,187 million yen.

“Even excluding some specific factors such as exchange gain and insurance income, we marked increases both in sales and profit this fiscal year. It is noteworthy that the sales of eyeglass lens business returned to the same level as before the Thai flooding in the fourth quarter, and the flexible endoscopes business developed sales in Middle East and Russia,” said Hiroshi Suzuki, chief executive officer of HOYA. “The earnings structure of the Information Technology segment is almost completed. For the next fiscal year, my focus is to grow sales of Life Care segment and at the same time to seek the opportunity for M&As.”

HOYA also announced year-end dividends forecast of 35 yen per share of common stock. The annual dividends, including the interim dividends of 30 yen per share, will amount to 65 yen per share. It will be decided at the board of directors meeting in the end of May.

 

Summary of Consolidated Financial Statement

(Millions of Yen: Rounded to the nearest million)
  Three months ended   Variance   Full year ended   Variance
  3/12   3/13 (%) 3/12   3/13 (%)
Revenue from all operations 87,525 96,095 9.8 376,940 372,494 -1.2
Profit before tax 17,661 29,965 69.7 58,530 89,368 52.7
Profit for the term 11,475 23,239 102.5 42,680 71,242 66.9
Basic earnings per share (yen)   28.13   53.76       100.18   164.78    

*Results are preliminary and unaudited.

 

The full reports are available at: www.hoya.co.jp/english/investor/

About HOYA

Founded in 1941 in Tokyo, Japan, Hoya is a global technology company and the leading supplier of innovative and indispensable high-tech/medical products based upon its advanced optics technologies. Hoya is active in the fields of Life Care and Information Technology providing eyeglasses, medical endoscopes, intraocular lenses, optical lenses as well as key components for the semiconductor devices, LCD panels and HDDs. Hoya now has over 100 subsidiaries and employs approximately 35,000 people worldwide. For more information, please visit http://www.hoya.co.jp/english/index.html

CONTACT

Hoya Group
Akiko Maeyama / Naoji Ito, +81-3-3952-3827
Corporate
Communications
HOYA-pr@mb.hoya.co.jp

同じカテゴリーの記事 

  • Avistone Announces the Approval of Vebreltinib as the First MET-TKI Treatment for a Rare Brain Glioma Subtype in China
  • Inocras Pioneers Precision Health with Revolutionary Whole Genome Insights
  • エクセルゲン、バクスター・インターナショナルを提訴。口腔体温計の精度に関するデータの公表権を擁護
  • パース・バイオサイエンシズが研究室用自動化プロバイダー・プログラムをローンチし、ハミルトン、オープントロンズ、ラボワークス、SPTラボテックと提携
  • Parse Biosciences与Hamilton、Opentrons Labworks和SPT Labtech合作推出实验室自动化供应商计划